Reliability and validity of an internalizing symptom scale based on the adolescent and adult Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA). by Acion, Laura et al.
UC San Diego
UC San Diego Previously Published Works
Title
Reliability and validity of an internalizing symptom scale based on the adolescent and adult 
Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA).
Permalink
https://escholarship.org/uc/item/8mc7502v
Journal
The American journal of drug and alcohol abuse, 45(2)
ISSN
0095-2990
Authors
Acion, Laura
Kramer, John
Liu, Xiangtao
et al.
Publication Date
2019
DOI
10.1080/00952990.2018.1476520
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=iada20
The American Journal of Drug and Alcohol Abuse
Encompassing All Addictive Disorders
ISSN: 0095-2990 (Print) 1097-9891 (Online) Journal homepage: https://www.tandfonline.com/loi/iada20
Reliability and validity of an internalizing symptom
scale based on the adolescent and adult Semi-
Structured Assessment for the Genetics of
Alcoholism (SSAGA)
Laura Acion, John Kramer, Xiangtao Liu, Grace Chan, Douglas Langbehn,
Kathleen Bucholz, Vivia McCutcheon, Victor Hesselbrock, Marc Schuckit,
Danielle Dick, Michie Hesselbrock & Samuel Kuperman
To cite this article: Laura Acion, John Kramer, Xiangtao Liu, Grace Chan, Douglas Langbehn,
Kathleen Bucholz, Vivia McCutcheon, Victor Hesselbrock, Marc Schuckit, Danielle Dick, Michie
Hesselbrock & Samuel Kuperman (2019) Reliability and validity of an internalizing symptom
scale based on the adolescent and adult Semi-Structured Assessment for the Genetics of
Alcoholism (SSAGA), The American Journal of Drug and Alcohol Abuse, 45:2, 151-160, DOI:
10.1080/00952990.2018.1476520
To link to this article:  https://doi.org/10.1080/00952990.2018.1476520
View supplementary material Published online: 05 Jun 2018.
Submit your article to this journal Article views: 115
View related articles View Crossmark data
Citing articles: 1 View citing articles 
METHODS IN ADDICTION RESEARCH
Reliability and validity of an internalizing symptom scale based on the
adolescent and adult Semi-Structured Assessment for the Genetics of
Alcoholism (SSAGA)
Laura Acion, PhDa,b,c, John Kramer, PhDa, Xiangtao Liu, PhDa, Grace Chan, PhDd, Douglas Langbehn, MD, PhDa,
Kathleen Bucholz, PhDe, Vivia McCutcheon, PhDe, Victor Hesselbrock, PhDd, Marc Schuckit, MDf, Danielle Dick,
PhDg, Michie Hesselbrock, PhDd, and Samuel Kuperman, MDa
aDepartment of Psychiatry, University of Iowa, Carver College of Medicine, Iowa City, IA, USA; bIowa Consortium for Substance Abuse
Research and Evaluation, Iowa City, IA, USA; cFundación Sadosky, Buenos Aires, Argentina; dDepartment of Psychiatry, University of
Connecticut Health Center, Farmington, CT, USA; eDepartment of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA;
fDepartment of Psychiatry, University of California, San Diego School of Medicine, La Jolla, CA, USA; gDepartment of Psychology, Virginia
Commonwealth University, Richmond, VA, USA
ABSTRACT
Background: The Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA) is an interview
that assesses psychiatric symptoms and diagnoses, including substance use disorders and anxiety and
mood (i.e., internalizing) disorders. Although the SSAGA is widely used, there exists no overall
internalizing characteristics scale based on items drawn from SSAGA’s mood and anxiety disorder
sections. Objectives: To design and assess a SSAGA-based measurement instrument capturing the
overall internalizing dimension that underlies more specific internalizing conditions. Methods: We
developed, assessed, and characterized a new scale for measuring internalizing problematic
characteristics derived from the SSAGA interview. All samples were drawn from the Collaborative
Studies on the Genetics of Alcoholism, a prospective multi-site genetic study of families at high risk for
alcohol use disorders. All participants taking part in the study between September 2005 and
September 2017 were eligible (n = 904, 52.2% female). Results: The scale had adequate internal
consistency (ordinal α = 0.85, 95% CI = [0.81, 0.89]). Construct validity was supported by its association
with other measures of internalizing characteristics (Internalizing Scale from Achenbach Self Reports;
Neuroticism Scale from the Neuroticism-Extraversion-Openness Five-Factor Personality Inventory).
Several indices of alcohol, marijuana, and nicotine misuse were also positively associated with
Internalizing Scale scores. Conclusions: The Internalizing Scale has very good psychometric properties
and can be used in studies that incorporate the SSAGA interview to study the association between
internalizing characteristics and problematic alcohol and other substance use. These associations can
potentially be utilized to identify individuals at risk for substance problems and to design treatments
targeting such individuals.
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Introduction
Child and adult psychopathology is sometimes broadly
dichotomized into externalizing problems and disor-
ders, involving characteristics such as impulsivity,
sensation seeking, and aggression, and internalizing
problems and disorders, involving characteristics such
as anxiety and depression (1). The robust association
between the externalizing domain and substance
problems is well documented (2). For example, young
adolescents with conduct disorder are at elevated risk to
develop alcohol use disorders in adulthood (3), and the
two diagnoses share some genetic (4) and electrophy-
siological (5,6) risk factors.
The internalizing domain has also been linked to
substance problems, although these relationships are
less frequently studied, particularly their longitudinal
links, and they are often smaller in magnitude than
those found for externalizing traits (7). Nevertheless,
internalizing conditions such as anxiety and mood dis-
orders are well known to co-occur with substance use
disorders at high rates (8,9). For example, persons with
internalizing disorders have two to eleven times the
odds of having alcohol dependence when compared to
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subjects without such psychiatric comorbidity (10). In
addition, internalizing disorders are associated with an
increased likelihood of relapse after substance treat-
ment (11), and there is some evidence for connections
between very early internalizing characteristics and
adult substance initiation and/or problems many years
later (12).
Internalizing characteristics are thought to involve
pathways of risk for alcohol and other substance
use disorders partially through themechanism of negative
reinforcement (13), that is, the reduction of unpleasant
emotional states through drinking, characterized behavio-
rally as “self-medication.” At a neurophysiological level,
this process is considered central to the second stage of
the brain disease model of addiction (14), which Koob
and colleagues refer to as withdrawal/negative affect (15).
Despite resurgent interest in this topic, the association
between internalizing characteristics and the initiation,
developmental course, and severity of alcohol and
substance use disorders is in need of considerable further
investigation. There are several methodological and his-
toric reasons for our relatively rudimentary knowledge.
Hussong and colleagues (2) note that internalizing traits
are more difficult than externalizing characteristics to
measure reliably during adolescence (the most common
onset period of substance use, including alcohol) and that
extended time frames (such as early childhood to
adulthood) are under-studied. Also, a long-standing over-
representation of males in addiction research may have
downplayed the potentially greater risk implications of
internalizing characteristics among female substance
users (2,16–18), for whom internalizing characteristics
are more prevalent (19,20).
From a methodological point of view, the aggrega-
tion of several measurements reflecting the same con-
struct is a common strategy to maximize the signal-to-
noise ratio of the behaviors or characteristics of interest
(21). For example, Kushner and colleagues (22)
obtained a positive association between alcohol depen-
dence and an overall internalizing construct (based on
both mood and anxiety symptoms). This trans-diagnos-
tic measure, which drew items from several specific
anxiety and mood diagnoses, was not improved by
the addition of these diagnoses to their model. An
additional advantage of aggregating across diagnoses
is the decreased number of statistical comparisons
needed.
The Semi-Structured Assessment for the Genetics of
Alcoholism (SSAGA) was developed by the Collaborative
Study on the Genetics of Alcoholism (COGA) for use in its
large-scale, multi-site study of alcohol use disorders.
The SSAGA is a comprehensive interview that obtains
information about physical, psychological, and social
manifestations of alcohol and other substance use disorders
in adolescents and adults (23–25) as part of its diagnostic
assessment of allmajorDiagnostic and StatisticalManual of
Mental Disorders (DSM5) psychiatric disorders (26). The
SSAGA also exhibits very good diagnostic reliability (25)
and validity (as measured by comparisons with diagnoses
obtained using best-estimate procedures (27) and with the
Schedule for Clinical Assessment in Neuropsychiatry) (24).
In sum, the SSAGA is an excellent instrument for assessing
current and past psychiatric problems in clinical and
general population samples. It has been used in over 250
studies in the theUnited States and has been translated into
9 foreign languages (Hesselbrock, personal communica-
tion). The SSAGA was previously used to study the
association between particular internalizing characteristics
and diagnoses (e.g., suicidality and major depressive dis-
order) and substance use disorders (28–34), but to our
knowledge, there exists no published report of an overall
trans-diagnostic internalizing symptom scale based on this
interview. Although the SSAGA has been shown to be
reliable and valid at the diagnostic level, it is also necessary
to establish the psychometric validity of scales derived from
it, such as the Internalizing Scale proposed in this article, for
the purposes of conducting high-quality research.
The primary aim of this work was to provide
researchers who use the SSAGA with a psychometri-
cally valid and well-characterized Internalizing Scale
that can be derived directly from the SSAGA without
the need for an additional instrument. Because the
SSAGA also contains items that can be used to measure
externalizing traits, it is hoped that our scale will enable
investigators to examine the relationship between inter-
nalizing and externalizing characteristics over time,
particularly in relation to substance use problems.
This article describes the development, assessment,
and characteristics of a SSAGA-based Internalizing
Scale for measuring internalizing problematic charac-
teristics that underlie more specific internalizing con-
ditions such as major depressive episode (22,35). We
assessed the Internalizing Scale for internal consistency
and construct validity. We hypothesized that the
Internalizing Scale scores would be higher in females
than in males and would be positively associated with
alcohol as well as other substance (i.e., nicotine and
marijuana) use disorder symptoms and characteristics.
Methods
Participants
The samples used for the development and validation of
the Internalizing Scale were drawn from the COGA, a
prospective multi-site genetic study of families at high risk
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for alcohol use disorders (AUD) (36,37). Institutional
Review Boards at all six sites reviewed and approved the
study. Parents provided consent for all offspring below 18;
individuals 13 and older also provided consent, and
children aged 12 provided assent.
All adolescents and adults who participated in
COGA between September 2005 and September 2017
were eligible for this study (n = 3834 in 904 families).
Only one subject was randomly drawn from each
family to prevent associations of observations within
families. Correlation within each site was accounted for
using bootstrap resampling at the site level to estimate
standard errors. The sample encompassed 904 partici-
pants and was randomly divided into two subsamples
(20% for development and 80% for validation). Sex,
age, household income, and self-reported race for
these samples are included in Table 1.
Scale development and content validity
Scale development and validation followed all relevant
consensus-based standards for the selection of health
measurement instruments (also known as COSMIN
guidelines) (38). We developed a 7-item scale by
extracting core diagnostic items from six lifetime
DSM5-compatible diagnoses: social phobia, panic
disorder, agoraphobia, obsessive compulsive disorder,
post-traumatic stress disorder, major depressive epi-
sode, and symptoms of suicidality from the SSAGA.
Suicidality was added because it can reflect depression
and anxiety not captured by other items. Because sui-
cide attempts can also contain impulsive, externalizing
elements, we only included attempts that (a) took place
in the context of depression; (b) did not take place in
the context of alcohol or drug use, psychosis, or mania;
and (c) were preceded by at least 7 days of premedita-
tion. Only symptoms and diagnoses occurring free of
the influence of alcohol, drugs, changes in medication,
co-occurring illnesses, or postpartum conditions con-
tributed to the Internalizing Scale total score. Higher
scores indicated more internalizing problematic
characteristics.
The Internalizing Scale was constructed by drawing
questions from several sections of the SSAGA interview
that address internalizing characteristics. Since the
SSAGA is a long and detailed assessment, several itera-
tions were considered prior to the version of the scale
presented in this article. Earlier versions of the
Internalizing Scale had up to 32 items with scores of 0
or 1, reflecting diagnostic criteria for the 6 disorders
contained within it. However, because these disorders
contain differing numbers of criteria, they were
unequally represented in the scale (e.g., agoraphobia
contributed two items, whereas obsessive-compulsive
disorder contributed eight). Later iterations balanced
the input of each disorder (see discussion later) and
added suicidal thoughts and behaviors from the
SSAGA. The final version of the Internalizing Scale,
reported in this article, provides superior item balance.
The current version also exhibits slight improvements
in terms of higher internal consistency, larger effect
sizes with scales used for validation, and larger effect
Table 1. Participant characteristics for development, content validity, and validation samples by age (adolescents: 12–17 years,
adults: 18+ years).
Development and content validity sample
(n = 181)
Validation sample
(n = 723)
Adolescents (n = 51) Adults (n = 130) Adolescents (n = 220) Adults (n = 503)
Interview age in years (mean, SD) 14.9 (1.7) 23.8 (6.7) 14.4 (1.9) 23.3 (5.6)
Sex (n, % female) 26 (51.0) 82 (63.1) 105 (47.7) 259 (51.5)
Self-reported ethnicity
European American (n, %) 38 (75.0) 90 (69.2) 154 (70.0) 352 (70.0)
African American (n, %) 11 (21.6) 32 (24.6) 53 (24.1) 108 (21.5)
Household income (median range/year) NA $20,000–$29,999a NA $30,000–$39,999b
YSR Internalizing Problems Raw Score (mean, median, Q1–Q3) 10.8, 9.0 (6.0–13.0)c NA 11.8, 10.0 (6.0–16.0)d NA
ASR Internalizing Problems Raw Score (mean, median, Q1–Q3) NA 13.8, 10.0 (5.0–20.0)e NA 13.8, 12.0 (4.0–20.0)f
NEO-FFI Neuroticism Scale (mean, SD) NA 50.7 (11.6)g NA 50.1 (11.7)h
Lifetime Internalizing Scale total score (mean, median, Q1–Q3) 0.68, 0 (0–0) 1.61, 0 (0–3) 0.80, 0 (0–1) 1.55, 0 (0–2)
aExcluded 9 (6.9%) participants whose responses were missing (either refused or unknown).
bExcluded 28 (5.6%) participants whose responses were missing (either refused or unknown).
cAvailable only for 31 (60.8%) participants.
dAvailable only for 130 (59.1%) participants.
eAvailable only for 37 (28.4%) participants.
fAvailable only for 153 (30.4%) participants.
gAvailable only for 32 (24.6%) participants.
hAvailable only for 134 (26.6%) participants.
NA: Not available. YSR: Achenbach Youth Self Report. ASR: Achenbach Adult Self Report. NEO-FFI: Neuroticism-Extraversion-Openness Five-Factor Personality
Inventory. SD: Standard deviation. Q1: First quartile. Q3: Third quartile.
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sizes with demographic and alcohol and other sub-
stance characteristics. It also performed slightly better
when heritability was measured in a genetic framework
(further details about this will be presented in a
publication currently in preparation). Although none
of these improvements reached statistical significance
on its own, we consider the sum of these improvements
supports the decision to change item balance. More
details about these results are omitted for the sake of
brevity.
Because internalizing disorders contain differing
numbers of criteria, we wished to construct a scale
that incorporated equal weighting or input from the
disorders. To accomplish this, the scale includes seven
items reflecting the six diagnoses and suicidality
(Table 2). Each of the 7 items is scored between 0 and
3. A score of 0 indicates no symptoms for the disorder
or symptoms of suicidality; a score of 1 indicates the
person has fewer than half the core symptoms for the
disorder and therefore (by DSM requirements) cannot
meet diagnostic criteria for the disorder (or, for suicid-
ality, the person has only thoughts about killing self); a
score of 2 is given when the person has half or more of
the symptoms for a disorder but does not meet full
diagnostic criteria (because symptom clustering and/or
functional impairment requirements are not met; or,
for suicidality, the person has both thoughts and plans
of killing self but no attempts); and a score of 3 is
Table 2. Description and scoring of the Internalizing Scale.
Disorder Item description Item score
Agoraphobia (AG) a. Anxiety about being in places or situations from which escape might be difficult
b. Situations are avoided or endured with marked distress
0: No symptoms
1: a. or b. present, but not both, and does
not meet AG dxa
2: a. and b. present, but does not meet AG
dx
3: AG dx met
Panic disorder (PD) a. Recurrent unexpected panic attacks 0: No symptoms
b. Discrete period of intense fear with 4+ symptoms (e.g., palpitation, sweating,
trembling) developed abruptly
c. At least one attack followed by 1+ month of 1+ of the following: (i) concern of
having additional attacks, (ii) worry about attack implications, (iii) significant change
of behavior
1: One of a. to c. present and does not meet
PD dx
2: More than one of a. to c. but does not
meet PD dx
3: PD dx met
Social phobia (SP) a. Marked and persistent fear of social or performance situations
b. Exposure to the feared social situation almost invariably provokes anxiety
c. Feared social situations avoided/endured with intense anxiety
0: No symptoms
1: One of a. to c. present and does not meet
SP dx
2: More than one of a. to c. but does not
meet SP dx
3: SP dx met
Obsessive compulsive
disorder (OCD)
a. Recurrent and persistent thoughts, impulses, or images
b. Thoughts, impulses, or images are not excessive worries about real-life problems
c. Attempts to ignore or suppress such thoughts, impulses, or images
d. Recognizes that obsessional thoughts/impulses/images are product of own mind
e. Repetitive behaviors/mental acts the person feels driven to perform
f. Behaviors/mental acts aimed at preventing distress/dreaded event or situation
g. Person recognizes obsessions/compulsions are excessive
0: No symptoms
1: Any combination of at most
3 of a. to g. present and does not meet OCD
dx
2: Any combination of more than 3 of a. to
g. but does not meet OCD dx
3: OCD dx met
Post-traumatic stress
disorder (PTSD)
a. Traumatic event is persistently re-experienced
b. Persistent avoidance of stimuli associated with the trauma and numbing of
general responsiveness
c. Persistent symptoms of increased arousal (e.g., hypervigilance)
0: No symptoms
1: One of a. to c. present and does not meet
PTSD dx
2: More than one of a. to c. but does not
meet PTSD dx
3: PTSD dx met
Major depressive
episode (MDE)
a. Depressed most of the day or markedly diminished interest or pleasure
b. Weight loss/gain or decrease/increase in appetite
c. Insomnia/hypersomnia
d. Psychomotor agitation/retardation
e. Fatigue/loss of energy
f. Worthlessness/guilt
g. Difficulty concentrating
h. Recurrent thoughts of death
0: No symptoms
1: Any combination of at most 4 of a. to h.
present and does not meet MDE dx
2: Any combination of more than 4 of a. to
h. present but does not meet MDE dx
3: MDE dx met
Suicidality a. Thoughts about killing self for at least 7 days in a row
b. Plans of killing self
c. Suicidal attempt while feeling depressed but not under other circumstances (e.g.,
drinking, psychosis) that may or may not require medical assistance
0: No symptoms
1: a. present but b. and c. absent
2: a. and b. present but c. absent
3: c. present
aAll diagnoses are compatible with DSM5 (26).
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assigned when a person meets diagnostic criteria for the
disorder (or has made at least one suicide attempt). The
resulting theoretical total range of the 7-item scale is
0–21. The algorithm used to calculate the total
Internalizing Scale score using SSAGA is provided as
supplementary material.
Factor analyses and internal consistency
Following the recommendations by Peters (21), we used
exploratory factor analysis (EFA) in the development
sample to determine the scale’s dimensionality based on
the polychoric correlation matrix of the scales’ items (39).
The factor structure in the development sample was then
confirmed through confirmatory factor analysis (CFA) in
the validation sample. Adequacy of fit was evaluated using
the root mean square error of approximation and the
comparative fit index. We used minimum rank factor
analysis to estimate the percentage of common variance
explained by the EFA and CFA models (40,41), and
parallel analysis (42) and the Bayesian information criter-
ion for factor retention. Closeness to unidimensionality
was assessed using the explained common variance
(ECV) (43).
Since the unidimensionality assumption was met, we
calculated ordinal standardized α (44), a statistic more
appropriate than Cronbach’s α for assessing internal
consistency of scales in which individual item scores
are ordinal (21,45,46).
Construct validity
Construct validity was assessed in three ways, using the
validation sample. First, we tested the associations between
the Internalizing Scale under development and the
Internalizing Scale from the Youth and Adult Achenbach
Self Reports. The Internalizing Scale from the Achenbach
Self Reports is a compilation of three syndrome scales
that tap psychological, emotional, and behavioral problems
associated with internalizing tendencies: Withdrawn (e.g.,
won’t talk), somatic complaints (e.g., headaches), and
anxious/depressed (e.g., nervous) (47,48). Second,we tested
the association between the Internalizing Scale under devel-
opment and the Neuroticism Scale from the Neuroticism-
Extraversion-Openness Five-Factor Personality Inventory
(49).We targeted the Neuroticism Scale because it includes
many internalizing characteristics, such as anxiety and
depression, and is strongly associated with both mood
and anxiety disorders (50). Because the Achenbach Self
Reports and Five-Factor Personality Inventory compari-
sons were conducted between an interview-based scale
and self-administered questionnaires (rather than between
two interview-based scales or between two questionnaires),
we hypothesized that validity correlations would bemodest
to moderate at best. Third, we examined the association of
the SSAGA-based Internalizing Scale with sex to address
our expectation that females would have higher scores than
males.
Associations with alcohol-related behavioral
characteristics and use of other substances
We also explored the association between the Internalizing
Scale with several alcohol-related variables, which included
(a) lifetime DSM5 AUD diagnosis, (b) number of AUD
symptoms, and (c) the total score of theDesires for Alcohol
Questionnaire, a measure of alcohol craving (51,52).
Associations between the scale and lifetime diagnoses and
number of substance use disorder symptoms for nicotine
and marijuana were also examined. All associations were
explored using the validation sample. Because the literature
suggests that internalizing characteristics are not strongly
associated with substance use and problems (e.g., (53,54)),
it was anticipated that the Internalizing Scale would exhibit
a modest positive relationship with the alcohol, nicotine,
and marijuana variables.
We used nonparametric Mann–Whitney tests for
group comparisons (i.e., male/female, having/not having
current AUD, having/not having current nicotine
dependence, having/not having marijuana dependence)
of the Internalizing Scale total score and report the
generalized Mann–Whitney (θ) effect size measure,
because the scales’ total scores were skewed to the
right. Theta expresses the degree of overlap of the
distributions of the two groups compared (θ’s theoretical
range is 0–1). The range extremes (0 and 1) indicate no
overlap between the distributions, while 0.5 indicates
complete overlap. Under the homoscedastic and normal
assumptions for each group, θ compares to Cohen’s d in
the following way: θ = 0.65 is equivalent to d = 0.55,
θ = 0.80 results in d = 1.19, and θ = 0.95 results in
d = 2.33 (55). We also used Spearman’s correlations (r)
to characterize bivariate associations of continuous vari-
ables. All statistical tests were performed using all data
available in each case, utilising SAS version 9.4 (56), R
(57), and FACTOR Version 10.7.01 x64bits (58).
Results
In the validation sample (n = 723), the mean
Internalizing Scale score was 1.32 (SD = 2.36, Q1 = 0,
median = 0, Q3 = 2, range = [0, 19], Figure 1).
Descriptive statistics were similar in the development
sample. Age-group-specific descriptive statistics of scale
scores are presented in Table 1. We examined all the
results that follow in adolescents and adults, unless
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otherwise stated. Results in each age group were similar
to the pooled ones presented.
Factor analyses and internal consistency
Parallel analysis based on minimum rank EFA performed
in the development sample recommended the extraction of
a single factor for the Internalizing Scale, suggesting uni-
dimensionality. Factor loadings for the EFA are reported in
Table 3. CFA in the validation sample confirmed these
findings. Single-factor models had good fit, as indicated
by RMSEA smaller than 0.05 and CFI larger than 0.95.
ECV was bigger than 0.81 both in the development and in
the validation samples, that is, more than 81% of the com-
mon variance in its items was explained by a single general
factor. A two-factor model showed goodness of fit (by
means of the RMSEA and CFI statistics) similar to the
single-factor model, but with a considerably larger BIC
(i.e., single-factor BIC = 143.29 vs. two-factor
BIC = 156.90). Parallel analysis did not support the two-
factor model either.
The Internalizing Scale exhibited adequate internal
consistency in the validation sample (ordinal α = 0.85,
95% CI = [0.81, 0.89]).
Construct validity
Table 1 displays characteristics of the samples used for
evaluating the associations between the SSAGA-based
Internalizing Scale and the Internalizing Scale from the
Youth and Adult Achenbach Self Reports, and the
Neuroticism Subscale of the Neuroticism-Extraversion-
Openness Five-Factor Personality Inventory. There was
a moderate association between the Internalizing Scale
from the Adult Achenbach Self Report and the
Neuroticism Subscale of the Five-Factor Personality
Inventory (r = 0.39; 95% CI = [0.18, 0.56]; p < 0.0001).
Positive associations between the Internalizing Scale and
the Internalizing Problems raw score of (a) the
Achenbach Adult Self Report (r = 0.40; 95%
CI = [0.25, 0.53]; p < 0.0001) and (b) the Achenbach
Youth Self Report (r = 0.35; 95% CI = [0.18, 0.50];
p < 0.0001) supported construct validity. The
Internalizing Scale was also positively associated with
the Neuroticism Subscale (r = 0.20; 95% CI = [0.03,
0.36]; p = 0.02), providing further support for construct
validity.
Females (n = 364, 50.3%) had higher INT Scale scores
than males (n = 359, 49.7%) (mean, median, Q1-Q3: [1.55,
0, 0–2.5] vs. [1.08, 0, 0–1]; θ = 0.94; 95% CI = [0.92, 0.96];
p = 0.0049), consistent with expectations.
Associations with alcohol-related behavioral
characteristics and use of other substances
Table 4 includes alcohol- and other substance-related
characteristics for each age group. Table 5 describes the
associations between AUD, nicotine dependence, and
marijuana use disorders with the Internalizing Scale.
Lifetime total scores for the scale were moderately
higher for subjects with these diagnoses than subjects
Figure 1. Distribution of the Internalizing Scale score in the
validation sample. SD: standard deviation. Q1: First quartile. Q3:
Third quartile.
Table 3. Factor loadings for the exploratory factor analysis
performed in the development sample.
Item Factor Loading
Agoraphobia 0.829
Panic disorder 0.858
Social phobia 0.709
Obsessive compulsive disorder 0.869
Post-traumatic stress disorder 0.596
Major depressive episode 0.542
Suicidality 0.701
Table 4. Alcohol- (AUD), nicotine- (ND), and marijuana-related
(MJUD) characteristics by age category in the validation sample.
Characteristic
Adolescents (12–
17 years, n = 220)
Adults (18+
years, n = 503)
Current AUD diagnosis (n, %) 14 (6.3) 174 (34.6)
Number of AUD symptoms
(mean, median, Q1–Q3)
0, 0 (0–0) 2, 1 (0–3)
Desires for alcohol total score
(mean, median, Q1–Q3)
27, 24 (21–32)a 29, 28 (23–36)b
Current ND diagnosis (n, %) 12 (5.5) 87 (17.3)
Number of ND symptoms
(mean, median, Q1–Q3)
0, 0 (0–0) 1, 0 (0–2)
Current MJUD diagnosis (n, %) 15 (6.8) 131 (26.0)
Number of MJUD symptoms
(mean, median, Q1–Q3)
0, 0 (0–0) 1, 0 (0–2)
aAvailable only for 30 adolescents of the 60 (27.3%) who ever had a full
drink of alcohol.
bAvailable only for 291 adults of the 455 (90.5%) who ever had a full drink
of alcohol.
Q1: First quartile. Q3: Third quartile.
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without the diagnoses. The number of AUD, nicotine
dependence, and marijuana use disorder symptoms,
and the Desires for Alcohol Questionnaire total score
were also modestly but positively associated with the
Internalizing Scale scores (see Table 5).
Discussion
The Internalizing Scale has very goodpsychometric proper-
ties and can be used, in studies that incorporate the SSAGA
interview, to study the association between lifetime inter-
nalizing characteristics and problematic alcohol and sub-
stance use. The scale is unidimensional and has good
internal consistency. Its validity is supported by associa-
tions with two other dimensional measures of internalizing
characteristics found in the Youth and Adult Achenbach
Self Report Internalizing Scales and the Neuroticism-
Extraversion-Openness Five-Factor Personality Inventory
Neuroticism Scale. Although just moderate, the magnitude
of the correlation between the proposed Internalizing Scale
and the Achenbach Internalizing Scale was similar to the
correlation between the Neuroticism Five-Factor
Personality Inventory Subscale and the Achenbach
Internalizing Scale. Our scale was more highly correlated
with the Achenbach Internalizing Scale than with the
Neuroticism Five-Factor Personality Inventory Subscale,
perhaps because the Achenbach Internalizing Scale is an
amalgam of disorder-based symptoms, most similar in
construction to the SSAGA-based Internalizing Scale. In
contrast, the lesser strength of the correlation between the
SSAGA-based Internalizing Scale and the Neuroticism
Scale may reflect the fact that the Neuroticism Scale does
not derive from specific disorders or diagnoses and includes
some non-internalizing traits, such as hostility. In sum,
these data suggest that our results are within range of
reasonable expectations.
The summary statistics for the Internalizing Scale
scores reveal that 75% of the sample scored a 2 or less
despite the instrument’s theoretical range of 0–21.
However, Figure 1 shows that, even though the distri-
bution is skewed to the right, the right tail of the
distribution is not driven by outliers, but rather by
the upper quartile of the sample where total scale scores
steadily decrease. We believe that the range of this scale
will accommodate populations with more internalizing
characteristics; predominantly female individuals or
patients ascertained for anxiety or mood disorders, for
example, might be reasonably expected to exhibit
higher mean and median statistics and to more fully
exploit the range of this instrument.
Also, as hypothesized, several indices of alcohol and
other drug misuse were positively associated with
higher scales’ scores. Furthermore, females had higher
internalizing scores than males, consistent with both
clinical observation and research (e.g., (19,20)). In
sum, the Internalizing Scale echoes SSAGA’s diagnostic
consistency and validity. It is important to acknowledge
the modest to moderate magnitude of relationships
between the scales and substance use variables. The
validation sample was young, with mean ages of 14.4
and 23.3 for the adolescent and young adult members,
respectively (Table 1). Although 34.6% of the adult
members had an AUD, only 6.3% of their adolescent
counterparts did (Table 4). For this younger group, the
full flowering of drug and alcohol involvement has not
yet occurred, and the relationship between internalizing
characteristics and substance misuse may be less robust
than at later stages of life (2,53). In addition, as men-
tioned earlier, internalizing characteristics are not as
strongly associated with substance misuse as are exter-
nalizing characteristics, particularly among relatively
young samples (e.g., (53)). The purpose of this work
was not to demonstrate a strong relationship between
internalizing characteristics and substance use but
rather to see if there was evidence for a positive link,
as suggested by the literature. Had there been no rela-
tionship, there would have been concerns about the
utility of this scale for studying addiction.
Strengths of this work include the high-quality and
large data set available to develop and characterize the
Internalizing Scale; for example, our sample size
allowed us to examine internalizing characteristics in
relation to sex. Also, we characterized the scale from
Table 5. Associations between the Internalizing Scale and
Alcohol- (AUD), nicotine- (ND), and marijuana-related (MJUD)
diagnoses and symptoms in the validation sample.
Internalizing Scale total score
Mean, median,
Q1–Q3 Theta 95% CI p
Current AUD diagnosis
Yes (n = 188) 2.15, 1, 0–3 0.79 0.75–0.83 <0.0001
No (n = 535) 1.02, 0, 0–1
Current ND diagnosis
Yes (n = 99) 2.22, 1, 0–3 0.68 0.63–0.74 0.0002
No (n = 624) 1.17, 0, 0–2
Current MJUD
diagnosis
Yes (n = 577) 1.74, 1, 0–3 0.71 0.66–0.75 0.001
No (n = 146) 1.20, 0, 0–2
n = 723 Spearman’s r 95% CI p
Number of AUD
symptoms
0.19 0.12–0.26 <0.0001
Desires for alcohol
total scorea
0.20 0.09–0.31 0.0003
Number of ND
symptoms
0.19 0.12–0.26 <0.0001
Number of MJUD
symptoms
0.12 0.05–0.19 0.001
aAvailable only for 321 (44.4%) individuals.
CI: Confidence interval. Q1: First quartile. Q3: Third quartile.
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multiple perspectives: construction, internal consis-
tency, and external validity.
There is a lack of test–retest reliability data for the scale.
However, Bucholz and colleagues (25) demonstrated good
one-week test–retest diagnostic reliability for the SSAGA.
Since the Internalizing Scale is, like diagnosis, based on
aggregations of single SSAGA questions, it is reasonable
to expect that its test–retest reliability might also be
acceptable. However, further work is needed to support
this hypothesis. Another limitation of this study was that
it includes data obtained across 12 years, where an accu-
mulation of differences in the administration or coding of
the SSAGA (interviewer drift) may have occurred.
However, interviewer- and site-specific drift in the
Collaborative Studies on the Genetics of Alcoholism have
been minimized by intensive interviewer training sessions
and monthly conference calls to review coding and proble-
matic subject responses (23). In addition, scales used
for assessing convergent validity were available only for
25%–60% of the participants (see Table 1). However, all
results reported in this article were similar when different
random samples of all data available were used and also
when a sample with complete data for all variables was
examined.
The scores reported in this work are true to diagnostic
guidelines; hence, any internalizing symptoms that
occurred in the context of alcohol and drug use, medica-
tion changes, co-occurring illness, or birth are scored as
absent. Depending on the intended use of the scores, this
could be an asset or an additional limitation. Our
approach makes most sense for scoring internalizing as
a precursor to the initiation, exacerbation, or recurrence
of substance problems, but might be problematic if scores
are examined as mediators or moderators between life
stressors or mental or physical illness and substance use.
This potential limitation can be easily addressed by a
minimal change in the code provided in the supplemen-
tary materials. These code changes permit the inclusion of
symptoms occurring in the context of substance use, ill-
ness, or other circumstances. The psychometric properties
of the Internalizing Scale based on these alterations are
similar to the results reported earlier (results not shown).
Data in the current analyses were cross-sectional, as is
much of the current knowledge about internalizing traits
and substance problems. However, data collected in the
ongoing COGA prospective study, which include the
SSAGA and, consequently, the Internalizing Scale, will
permit longitudinal investigations of multivariable associa-
tions between internalizing trans-diagnostic characteristics,
problematic substance use, and the temporal relationship
between them. It is hoped that the examination of genetic
and neurophysiological underpinnings of internalizing
characteristics will also be well served by this scale.
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